Marc Campet
Regional Aquaculture Business Developer
ADM Animal Nutrition
Vietnam
Marc directs the commercial development strategy for ADM’s aquaculture division across Asia. Based in Vietnam since 1995, Marc has dedicated his entire professional career to advancing aquaculture development within the region. He possesses over 20 years of specialized experience with ADM (formerly Neovia), focusing primarily on aquafeed development and commercial operations.
Throughout his tenure, Marc has held various progressive roles ranging from technical field operations to research and development (R&D). In his current leadership capacity, he drives regional growth by coordinating expansion strategies, managing the aquaculture product portfolio, and leading high-value initiatives. Furthermore, he partners with regional technical and innovation teams to launch new projects, while developing optimized business frameworks designed to maximize both profitability and market share for the company.
Risk and Health Management with Functional Feeds
Abstract
The rapid intensification of Asian aquaculture has heightened animal vulnerability to environmental fluctuations, climate anomalies, and pathogenic pressures. Traditional commercial diets frequently fail to mitigate these dynamic regional stressors, making functional aquafeeds critical to the future of the industry.
Formulations enriched with specialized additives—such as probiotics, prebiotics, and immunostimulants—actively enhance gut integrity, maximize nutrient absorption, and boost immunological defenses in target species. To address these localized challenges, robust internal research and development (R&D) capabilities are vital. Global operators including ADM Animal Nutrition leverage extensive R&D networks to engineer precisely tailored nutritional solutions, allowing for rapid field-testing and geographical customization.
A distinct competitive advantage is unlocked through the strategic synergy between the Feed Additives & Ingredients (FA&I) business and core aquafeed production. This integration facilitates the direct transfer of cutting-edge bioprocessing technologies—such as the Pichia guilliermondii yeast platform into commercial lines aquafeed, a legacy from Ocialis.
The empirical value of this model is validated through global field trials on different species: milkfish in the Philippines, barramundi and sturgeon in Vietnam through collaborative trials with key account customers to demonstrate how functional diets mitigate climate and seasonal stress for high value finfish. Concurrently, trials in Brazil evaluate specialized pre-vaccination feeds for tilapia, validating enhanced recovery and maximized vaccine efficacy under intensive production frameworks. By bridging advanced ingredient science with scalable manufacturing and real-world field validation, this corporate framework optimizes zootechnical performance, reduces environmental footprints, and secures long-term profitability across Asia.
In this presentation, we focus on the impact of functional feeds with field trials in Philippines and Vietnam, and in Brazil with pre-vaccination feed for the tilapia.
*Joint presentation with Mai Chung
© TARS 2026 – The Aquaculture Roundtable Series®